HemaCare Co. (OTCMKTS:HEMA – Get Free Report)’s share price shot up 0.6% during mid-day trading on Thursday . The stock traded as high as $25.31 and last traded at $25.31. 5,400 shares changed hands during mid-day trading, a decline of 86% from the average session volume of 39,950 shares. The stock had previously closed at $25.16.
HemaCare Stock Up 0.6%
The company’s fifty day simple moving average is $25.31 and its 200-day simple moving average is $25.31.
HemaCare Company Profile
HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy.
Featured Stories
- Five stocks we like better than HemaCare
- Growth Stocks: What They Are, What They Are Not
- Turbulence for Joby Shares: What’s Behind the Recent Dip?
- How to Invest in the FAANG Stocks
- Why Carnival Could Be the Ultimate Non-Tech Growth Stock
- When to Sell a Stock for Profit or Loss
- Super Micro Computer Stock Clears New Path Higher on Saudi Orders
Receive News & Ratings for HemaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HemaCare and related companies with MarketBeat.com's FREE daily email newsletter.
